![](/img/cover-not-exists.png)
Superimposable outcomes for sequential and concomitant administration of adjuvant trastuzumab in HER2-positive breast cancer: Results from the SIGNAL/PHARE prospective cohort
Pivot, X., Pierga, J-Y., Delaloge, S., Fumoleau, P., Bonnefoi, H., Bachelot, T., Jouannaud, C., Bourgeois, H., Rios, M., Soulie, P., Jacquin, J.P., Lavau-Denes, S., Kerbrat, P., Faure Mercier, C., PauVolume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw364.01
Date:
October, 2016
File:
PDF, 40 KB
english, 2016